Clinical Trials
16 trialsNCT07643519 2026-06-11
Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma
University of Florida
Phase 2 Not yet recruiting
NCT07260162 2026-06-08
PERSEVERANCE
Institut Cancerologie de l'Ouest
Phase 1 Not yet recruiting
NCT07608224 2026-05-27
HOPE-07-MIBC
West China Hospital
Phase 2/3 Not yet recruiting
NCT07579195 2026-05-14
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
University of Washington
Phase 1/2 Not yet recruiting
NCT07231809 2026-05-06
HIVEC
AC.TA. S.r.l.
Phase NA Not yet recruiting
NCT07548476 2026-05-04
ACE
Dana-Farber Cancer Institute
Phase NA Not yet recruiting
NCT07414992 2026-05-01
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Not yet recruiting
NCT07463963 2026-04-30
RUPTURE
Poitiers University Hospital
Phase NA Not yet recruiting
NCT07555756 2026-04-29
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
First Affiliated Hospital of Guangxi Medical University
Phase NA Not yet recruiting
NCT07555769 2026-04-29
CALCIFER
Zealand University Hospital
Phase 1 Not yet recruiting
NCT07529639 2026-04-14
Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
Assiut University
Not yet recruiting
NCT07525349 2026-04-13
Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
Assiut University
Not yet recruiting
NCT07503795 2026-03-31
Outcomes of Definitive Radiotherapy for Bladder Cancer
Sohag University
Not yet recruiting
NCT06834204 2026-03-23
ACCESS-PC
Rutgers, The State University of New Jersey
Phase NA Not yet recruiting
NCT07480356 2026-03-18
ADVANCED-3
Protara Therapeutics
Phase 3 Not yet recruiting
NCT07468838 2026-03-16
UroDNA
Institut Cancerologie de l'Ouest
Not yet recruiting